Levocarnitine and Pregabalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levocarnitine (levocarnitine) and Pregabalin (pregabalin). Common drug interactions include nasopharyngitis among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Levocarnitine and Pregabalin. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.



On Jul, 06, 2026

35 people who take Levocarnitine and Pregabalin together, and have interactions are studied.

Levocarnitine and Pregabalin drug interactions.

What are the common drug interactions of Levocarnitine and Pregabalin, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Neuropathy peripheral (surface nerve damage)
  3. Pancreatic mass
  4. Paraplegia (paralysis of the legs and lower body)
  5. Pelvic abscess
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Poor quality sleep
  8. Pruritus (severe itching of the skin)
  9. Sacral pain (pain at sacrum bone region)
  10. Shunt infection

male:

  1. Death
  2. Abnormal dreams
  3. Hepatocellular carcinoma (liver cancer)
  4. Herpes zoster
  5. Hypotension (abnormally low blood pressure)
  6. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  7. Incontinence (lack of moderation or self-control)
  8. Lumbar vertebral fracture
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Oral surgery

What are the common drug interactions of Levocarnitine and Pregabalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Necrotising oesophagitis (life threatening infection of oesophagus)
  2. Long qt syndrome (disorder of the heart's electrical system)
  3. Lung disorder (lung disease)
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

20-29:

  1. Craniocerebral injury (injury to cranium and brain)
  2. Decreased appetite
  3. Dementia (madness)
  4. Incontinence (lack of moderation or self-control)
  5. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  6. Pain in extremity
  7. Pelvic abscess
  8. Peripheral swelling
  9. Road traffic accident
  10. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

30-39:

  1. Abnormal dreams
  2. Social avoidant behaviour (avoiding social connection a personality disorder)
  3. Suicidal ideation

40-49:

n/a

50-59:

  1. Fatigue (feeling of tiredness)
  2. Acne (skin problems that cause pimples)
  3. Glaucoma (increased fluid pressure in the eye with vision loss)
  4. Hypersensitivity
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  6. Migraine (headache)
  7. Nervousness
  8. Ocular hyperaemia (an abnormally large amount of blood in eye)
  9. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
  10. Rash

60+:

  1. Cancer pain
  2. Drug eruption (adverse drug reaction of the skin)
  3. Dental caries
  4. General physical health deterioration (weak health status)
  5. Hepatocellular carcinoma (liver cancer)
  6. Herpes zoster
  7. Hypotension (abnormally low blood pressure)
  8. Lumbar vertebral fracture
  9. Oral surgery
  10. Paraplegia (paralysis of the legs and lower body)

What are the existing conditions these people have? *

  1. Pain: 3 people, 8.57%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.71%
  3. Rashes (redness): 2 people, 5.71%
  4. Oesophageal Squamous Cell Carcinoma (cancer that begins in flat cells lining the oesophagus): 2 people, 5.71%
  5. Neuropathy Peripheral (surface nerve damage): 2 people, 5.71%
  6. Mucosal Inflammation (infection of mucous membrane): 2 people, 5.71%
  7. High Blood Pressure: 2 people, 5.71%
  8. Cough: 2 people, 5.71%
  9. Cachexia (loss of weight): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and Pregabalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levocarnitine and Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levocarnitine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pregabalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levocarnitine and pregabalin (the active ingredients of Levocarnitine and Pregabalin, respectively), and Levocarnitine and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: